Cannabinoid hyperemesis syndrome with extreme hydrophilia

International Journal of General Medicine

Volumn 6, Issue , 2013, Pages 685-687

  Eenuh, Hilary A ^a   Chin, Julia ^a   Nfonoyim, Jay ^a  

^a RICHMOND UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cannabinoid; Compulsive bathing; Cyclic vomiting; Hydrophilia; Hyperemesis; Marijuana

Indexed keywords

CANNABIS; ONDANSETRON; OPIATE;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADULT; ARTICLE; BATH; CANNABINOID HYPEREMESIS; CANNABIS ADDICTION; CASE REPORT; CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; DRUG WITHDRAWAL; EPILEPSY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTRACTABLE PAIN; MALE; MEDICAL HISTORY; NAUSEA; OBSESSIVE COMPULSIVE DISORDER; PATIENT REFERRAL; URINALYSIS; VOMITING;

EID: 84883153902     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S49701     Document Type: Article

References (13)

1. Leggett T. A review of the world cannabis situation. Bull Narc. 2006;58(1-2):1-155.
2. Patterson D, Smith E, Monahan M, etal. Cannabinoid hyperemesis and compulsive bathing: a case series and paradoxical pathophysiological explanation. J Am Board Fam Med. 2010;23(6):790-793.
3. Mayo Clinic. Obsessive-compulsive disorder (OCD): definition. 2010. Available from: http://www.mayoclinic.com/health/obsessive-compulsive-disorder/DS00189. Accessed June 29, 2013.
4. Wikipedia. Obsessive-compulsive disorder. 2013. Available from http://en.wikipedia.org/wiki/Obsessive%E2%80%93compulsive_disorder. Accessed July 1, 2013.
5. Sontineni, Chaudhary S, Sontineni V, Lanspa S. Cannabinoid hyperemesis syndrome: clinical diagnosis of an under recognised manifestation of chronic cannabis abuse. World J Gastroenterol. 2009;15(10): 1264-1263.
6. Allen JH, De Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53(11):1566-1570.
7. Croxford JL. Therapeutic potential of cannabinoids in CNS disease. CNS Drugs. 2003;17(3):179-202.
8. González S, Cebeira M, Fernández-Ruiz J. Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav. 2005;81(2):300-308.
9. Darmani NA, Crim JL. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva). Pharmacol Biochem Behav. 2005;80(1):35-44.
10. Chang YH, Windish DM. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc. 2009;84(1):76-78.
11. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut. 2008;57(8): 1140-1155.
12. Simonetto D, Oxentenko A, Herman M, Szostek J. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc. 2012;87(2): 114-119.
13. Wallace E, Andrews S, Garmany C, Jelley M. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm. South Med J. 2011;104(9):659-664.